Shots:
- Cepheid has received IVDR CE marking for the Xpert GI Panel, a multiplex PCR assay designed to detect 11 clinically relevant GI pathogens from a single stool sample using the 10-color multiplexing technology on GeneXpert Systems
- The assay simultaneously identifies bacterial, viral, & parasitic pathogens directly from stool specimens in Cary-Blair transport media, requiring <1min. of hands-on time & delivering results in ~74min.
- The Xpert GI Panel expands Cepheid’s GI diagnostics portfolio, which already incl. PCR-based tests for Clostridioides difficile & norovirus. Shipments of the panel to CE mark-accepting countries are expected to begin in the coming wks.
Ref: PRnewswire | Image: Cepheid | Press Release
Related News: Tolion Health AI Launches AI-Powered Tolion Brain Coach App for Brain Health, Longevity, and Prevention of Alzheimer’s Disease
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
